1. Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer. (1st March 2021) Authors: Zhou, Li; Xu, Qiuli; Huang, Litang; Jin, Jiajia; Zuo, Xueying; Zhang, Qun; Ye, Liang; Zhu, Suhua; Zhan, Ping; Ren, Jianan; Lv, Tangfeng; Song, Yong Journal: Cancer letters Issue: Volume 500(2021) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗